Silicone Stent Versus Fully Covered Metallic Stent in Malignant Central Airway Stenosis

Simple item page
dc.contributor.authorOrtiz-Comino, Rosa Maria
dc.contributor.authorMorales, Arturo
dc.contributor.authorLópez-Lisbona, Rosa
dc.contributor.authorCubero, Noelia
dc.contributor.authorDiez-Ferrer, Marta
dc.contributor.authorTebé, Cristian
dc.contributor.authorRosell, Antoni
dc.contributor.authorESCODULE Study Group
dc.date.accessioned2022-05-04T20:41:57Z
dc.date.available2022-05-04T20:41:57Z
dc.date.issued2021
dc.description.abstractBackground: Airway stenting to restore airway patency in cases of malignant central airway obstruction is an effective palliation treatment. Our goal was to compare the efficacy after deployment and complications of a fully covered self-expandable metal stent (SEMS) (Aerstent) and a silicone stent (Dumon). Methods: This was a retrospective cohort of 2 similar groups of patients with malignant central airway obstruction treated with stents between August 2012 and July 2017. Complications were assessed bronchoscopically. A competing risk for death analysis was performed to adjust the probability of developing a complication. Results: Seventy patients (29 with silicone stents and 41 with SEMS) were included. Stent insertion was successful in all cases. Mucus retention was the most frequent complication (75.9% with silicone stents and 84.8% with SEMS; P = .51), followed by granulation tissue (51.7% with silicone stents and 41.3% with SEMS; P = .52) and migration (6.9% with silicone stents and 13.0% with SEMS; P = .47). In the first month, the cumulative incidence of a complication was 36.7% for silicone stents and 41.3% for SEMS and increased to 90.0% and 97.8% after 6 months, respectively (hazard ratio = 1.66; P = .04). A competing risk for death analysis showed an adjusted hazard ratio of 1.41 (P = .49) indicating no differences in overall complications between stents. Conclusions: Both stents were equally successful and safe. The incidence of complications increased over time to 90% at 6 months for both stents. The risk of overall complications was higher for SEMS; nevertheless, when mortality was measured in a competitive risk analysis, no differences were found between SEMS and silicone stents.es
dc.description.versionVersión Publicadaes
dc.identifier.citationOrtiz-Comino RM, Morales A, López-Lisbona R, Cubero N, Diez-Ferrer M, Tebé C, Rosell A; ESCODULE Study Group. Silicone Stent Versus Fully Covered Metallic Stent in Malignant Central Airway Stenosis. Ann Thorac Surg. 2021 Jan;111(1):283-289. doi: 10.1016/j.athoracsur.2020.04.141. Epub 2020 Jun 23. PMID: 32589886.es
dc.identifier.urihttps://doi.org/10.1016/j.athoracsur.2020.04.141es
dc.identifier.urihttp://hdl.handle.net/11447/6057
dc.language.isoenes
dc.subjectSiliconeses
dc.subjectStentses
dc.subjectAdverse effectses
dc.titleSilicone Stent Versus Fully Covered Metallic Stent in Malignant Central Airway Stenosises
dc.typeArticlees
dcterms.sourceThe Annals of Thoracic Surgeryes

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-s2.0-S0003497520309632-main.pdf
Size:
274.67 KB
Format:
Adobe Portable Document Format
Description:
Texto completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services